Articles:

Therapeutic innovation: the up-front window

E Frei, 3rd
Clin Cancer Res 1998 4: 2573 [PDF]  

Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas

WM Lin, E Forgacs, DP Warshal, IT Yeh, JS Martin, R Ashfaq, and CY Muller
Clin Cancer Res 1998 4: 2577 [Abstract] [PDF]  

Association between cyclin D1 (CCND1) gene amplification and human papillomavirus infection in human laryngeal squamous cell carcinoma

P Cattani, S Hohaus, A Bellacosa, M Genuardi, S Cavallo, V Rovella, G Almadori, G Cadoni, J Galli, M Maurizi, G Fadda, and G Neri
Clin Cancer Res 1998 4: 2585 [Abstract] [PDF]  

Metabolic and hemodynamic evaluation of brain metastases from small cell lung cancer with positron emission tomography

U Lassen, P Andersen, G Daugaard, S Holm, M Jensen, C Svarer, HS Poulsen, and OB Paulson
Clin Cancer Res 1998 4: 2591 [Abstract] [PDF]  

Phase II clinical trial of bolus infusion anti-B4 blocked ricin immunoconjugate in patients with relapsed B-cell non-Hodgkin's lymphoma

PS Multani, S O'Day, LM Nadler, and ML Grossbard
Clin Cancer Res 1998 4: 2599 [Abstract] [PDF]  

Expression of MUC1 and MUC2 mucins in gastric carcinomas: its relationship with the prognosis of the patients

T Utsunomiya, S Yonezawa, H Sakamoto, H Kitamura, S Hokita, T Aiko, S Tanaka, T Irimura, YS Kim, and E Sato
Clin Cancer Res 1998 4: 2605 [Abstract] [PDF]  

Expression of p21WAF1 predicts outcome of esophageal cancer patients treated by surgery alone or by combined therapy modalities

M Sarbia, M Stahl, A zur Hausen, K Zimmermann, L Wang, U Fink, H Heep, P Dutkowski, R Willers, W Muller, S Seeber, and HE Gabbert
Clin Cancer Res 1998 4: 2615 [Abstract] [PDF]  

Vascular integrin alpha(v)beta3: a new prognostic indicator in breast cancer

G Gasparini, PC Brooks, E Biganzoli, PB Vermeulen, E Bonoldi, LY Dirix, G Ranieri, R Miceli, and DA Cheresh
Clin Cancer Res 1998 4: 2625 [Abstract] [PDF]  

Antagonistic effects of systemic interleukin 2 on immune Tcell-mediated graft-versus-leukemia reactivity

V Schirrmacher, S Muerkoster, and V Umansky
Clin Cancer Res 1998 4: 2635 [Abstract] [PDF]  

Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect

K Reiss, C D'Ambrosio, X Tu, C Tu, and R Baserga
Clin Cancer Res 1998 4: 2647 [Abstract] [PDF]  

Alpha-cyano-beta-hydroxy-beta-methyl-N-[4-(trifluoromethoxy)phenyl] propenamide: an inhibitor of the epidermal growth factor receptor tyrosine kinase with potent cytotoxic activity against breast cancer cells

S Ghosh, Y Zheng, X Jun, RK Narla, S Mahajan, C Navara, C Mao, EA Sudbeck, and FM Uckun
Clin Cancer Res 1998 4: 2657 [Abstract] [PDF]  

Selection of tumor antigens as targets for immune attack using immunohistochemistry: protein antigens

S Zhang, HS Zhang, C Cordon-Cardo, G Ragupathi, and PO Livingston
Clin Cancer Res 1998 4: 2669 [Abstract] [PDF]  

A phase II "window" study of topotecan in untreated patients with high risk adult acute lymphoblastic leukemia

SD Gore, EK Rowinsky, CB Miller, C Griffin, TL Chen, M Borowitz, RC Donehower, KL Burks, DK Armstrong, PJ Burke, MR Grever, and SH Kaufmann
Clin Cancer Res 1998 4: 2677 [Abstract] [PDF]  

Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma

FM Foss, A Raubitscheck, JL Mulshine, TA Fleisher, JC Reynolds, CH Paik, RD Neumann, C Boland, P Perentesis, MR Brown, JM Frincke, CP Lollo, SM Larson, and JA Carrasquillo
Clin Cancer Res 1998 4: 2691 [Abstract] [PDF]  

Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors

A Korfel, ME Scheulen, HJ Schmoll, O Grundel, A Harstrick, M Knoche, LM Fels, M Skorzec, F Bach, J Baumgart, G Sass, S Seeber, E Thiel, and WE Berdel
Clin Cancer Res 1998 4: 2701 [Abstract] [PDF]  

Dendritic cell-based vaccines in the setting of peripheral blood stem cell transplantation: CD34+ cell-depleted mobilized peripheral blood can serve as a source of potent dendritic cells

D Choi, M Perrin, S Hoffmann, AE Chang, V Ratanatharathorn, J Uberti, KT McDonagh, and JJ Mule
Clin Cancer Res 1998 4: 2709 [Abstract] [PDF]  

Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer

Z Rahman, J Kavanagh, R Champlin, R Giles, E Hanania, S Fu, Z Zu, R Mehra, F Holmes, A Kudelka, D Claxton, C Verschraegen, J Gajewski, M Andreeff, S Heimfeld, R Berenson, D Ellerson, L Calvert, E Mechetner, T Holzmayer, A Dayne, J Hamer, C Bachier, J Ostrove, and A Deisseroth
Clin Cancer Res 1998 4: 2717 [Abstract] [PDF]  

Superiority of sequential versus concurrent administration of paclitaxel with etoposide in advanced non-small cell lung cancer: comparison of two Phase II trials

E Felip, B Massuti, C Camps, D Benito, D Isla, JL Gonzalez-Larriba, MP Lopez-Cabrerizo, O Salamanca, J Puerto-Pica, A Moyano, J Baselga, and R Rosell
Clin Cancer Res 1998 4: 2723 [Abstract] [PDF]  

Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma

CR Divgi, NH Bander, AM Scott, JA O'Donoghue, G Sgouros, S Welt, RD Finn, F Morrissey, P Capitelli, JM Williams, D Deland, A Nakhre, E Oosterwijk, S Gulec, MC Graham, SM Larson, and LJ Old
Clin Cancer Res 1998 4: 2729 [Abstract] [PDF]  

Photodynamic therapy using mono-L-aspartyl chlorin e6 (Npe6) for the treatment of cutaneous disease: a Phase I clinical study

SW Taber, VH Fingar, CT Coots, and TJ Wieman
Clin Cancer Res 1998 4: 2741 [Abstract] [PDF]  

Irinotecan (CPT-11) metabolism and disposition in cancer patients

A Sparreboom, MJ de Jonge, P de Bruijn, E Brouwer, K Nooter, WJ Loos, RJ van Alphen, RH Mathijssen, G Stoter, and J Verweij
Clin Cancer Res 1998 4: 2747 [Abstract] [PDF]  

A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors

J Cassidy, L Dirix, D Bissett, B Reigner, T Griffin, D Allman, B Osterwalder, and AT Van Oosterom
Clin Cancer Res 1998 4: 2755 [Abstract] [PDF]  

A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies

M Hidalgo, G Rodriguez, JG Kuhn, T Brown, G Weiss, JP MacGovren, DD Von Hoff, and EK Rowinsky
Clin Cancer Res 1998 4: 2763 [Abstract] [PDF]  

Elevated serum levels of Trichosanthes japonica agglutinin-I binding alkaline phosphatase in relation to high-risk groups for hepatocellular carcinomas

K Fukushima, T Hada, K Higashino, and K Yamashita
Clin Cancer Res 1998 4: 2771 [Abstract] [PDF]  

Identification of high-risk patients by assessment of nuclear Ki-67 expression in a prospective study of endometrial carcinomas

HB Salvesen, OE Iversen, and LA Akslen
Clin Cancer Res 1998 4: 2779 [Abstract] [PDF]  

Loss of heterozygosity at 11q23 in squamous cell carcinoma of the head and neck is associated with recurrent disease

AD Lazar, MR Winter, CP Nogueira, PS Larson, EM Finnemore, RW Dolan, N Fuleihan, A Chakravarti, A Zietman, and CL Rosenberg
Clin Cancer Res 1998 4: 2787 [Abstract] [PDF]  

High tumor angiogenesis is associated with poorer survival in carcinoma of the cervix treated with radiotherapy

RA Cooper, DP Wilks, JP Logue, SE Davidson, RD Hunter, SA Roberts, and CM West
Clin Cancer Res 1998 4: 2795 [Abstract] [PDF]  

Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers

IY Cheung, D Barber, and NK Cheung
Clin Cancer Res 1998 4: 2801 [Abstract] [PDF]  

Detection of human telomerase reverse transcriptase messenger RNA in voided urine samples as a useful diagnostic tool for bladder cancer

H Ito, S Kyo, T Kanaya, M Takakura, K Koshida, M Namiki, and M Inoue
Clin Cancer Res 1998 4: 2807 [Abstract] [PDF]  

Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells

Q Ren, V Kao, and JL Grem
Clin Cancer Res 1998 4: 2811 [Abstract] [PDF]  

DNA vaccination with HuD inhibits growth of a neuroblastoma in mice

AF Carpentier, MR Rosenfeld, JY Delattre, RG Whalen, JB Posner, and J Dalmau
Clin Cancer Res 1998 4: 2819 [Abstract] [PDF]  

A single-chain immunotoxin against carcinoembryonic antigen that suppresses growth of colorectal carcinoma cells

Y Akamatsu, JC Murphy, KF Nolan, P Thomas, RJ Kreitman, SO Leung, and RP Junghans
Clin Cancer Res 1998 4: 2825 [Abstract] [PDF]  

Improved efficacy and enlarged spectrum of activity of a novel anthracycline disaccharide analogue of doxorubicin against human tumor xenografts

G Pratesi, M De Cesare, C Caserini, P Perego, L Dal Bo, D Polizzi, R Supino, M Bigioni, S Manzini, E Iafrate, C Salvatore, A Casazza, F Arcamone, and F Zunino
Clin Cancer Res 1998 4: 2833 [Abstract] [PDF]  

Inhibition of apoptosis after thymineless stress is conferred by oncogenic K-Ras in colon carcinoma cells

JA Houghton, R Ebanks, FG Harwood, and DM Tillman
Clin Cancer Res 1998 4: 2841 [Abstract] [PDF]  

Effects of recombinant neutral endopeptidase (EC 3.4.24.11) on the growth of lung cancer cell lines in vitro and in vivo

PA Bunn, Jr, BA Helfrich, DG Brenner, DC Chan, DJ Dykes, AJ Cohen, and YE Miller
Clin Cancer Res 1998 4: 2849 [Abstract] [PDF]  

Antileukemia activity of a natural killer cell line against human leukemias

Y Yan, P Steinherz, HG Klingemann, D Dennig, BH Childs, J McGuirk, and RJ O'Reilly
Clin Cancer Res 1998 4: 2859 [Abstract] [PDF]  

Growth inhibitory effects of 1,25-dihydroxyvitamin D3 and its synthetic analogue, 1alpha,25-dihydroxy-16-ene-23yne-26,27-hexafluoro-19-nor-cholecalcifero l (Ro 25-6760), on a human colon cancer xenograft

SR Evans, AM Schwartz, EI Shchepotin, M Uskokovic, and IB Shchepotin
Clin Cancer Res 1998 4: 2869 [Abstract] [PDF]  

Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts

JA Bennett, S Zhu, A Pagano-Mirarchi, TA Kellom, and HI Jacobson
Clin Cancer Res 1998 4: 2877 [Abstract] [PDF]  

Flavopiridol mediates cell cycle arrest and apoptosis in esophageal cancer cells

DS Schrump, W Matthews, GA Chen, A Mixon, and NK Altorki
Clin Cancer Res 1998 4: 2885 [Abstract] [PDF]  

Pharmacokinetics of O6-benzylguanine and its active metabolite 8-oxo-O6-benzylguanine in plasma and cerebrospinal fluid after intrathecal administration of O6-benzylguanine in the nonhuman primate

SL Berg, DJ Murry, CL McCully, K Godwin, and FM Balis
Clin Cancer Res 1998 4: 2891 [Abstract] [PDF]  

Dipyridamole potentiates antipurine antifolate activity in the presence of hypoxanthine in tumor cells but not in normal tissues in vitro

E Marshman, DR Newell, AH Calvert, AM Dickinson, HR Patel, FC Campbell, and NJ Curtin
Clin Cancer Res 1998 4: 2895 [Abstract] [PDF]  

Polynucleotide immunization of nonhuman primates against carcinoembryonic antigen

RM Conry, SA White, PN Fultz, MB Khazaeli, TV Strong, KO Allen, DL Barlow, SE Moore, PN Coan, I Davis, DT Curiel, and AF LoBuglio
Clin Cancer Res 1998 4: 2903 [Abstract] [PDF]  

Bcl-2 but not Bax expression is associated with apoptosis in normal and transformed squamous epithelium

SD Drenning, AJ Marcovitch, DE Johnson, MF Melhem, DJ Tweardy, and JR Grandis
Clin Cancer Res 1998 4: 2913 [Abstract] [PDF]  

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.